Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non - insulin-dependent diabetic patients with primary hypertension

American Journal of Hypertension

Volumn 5, Issue 5, 1992, Pages 257-265

  Gall, Mari Anne ^a   Rossing, Peter ^a   Skott, Peter ^a   Hommel, Eva ^a   Mathiesen, Elisabeth R ^a   Gerdes, Lars U ^a   Lauritzen, Mogens ^a   Volund, Aage ^a   Fcergeman, Ole ^a   Beck Nielsen, Henning ^a   Pawing, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Antihypertensive therapy; Kidney function; Metabolic control; Non insulin dependent diabetes mellitus; Primary hypertension

Indexed keywords

CAPTOPRIL; HYDROCHLOROTHIAZIDE; METOPROLOL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

AGED; CAPTOPRIL; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMAN; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; METOPROLOL; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0026591052     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/5.5.257     Document Type: Article

References (46)

1. Klein R, Klein BEK, Moss SE, et al: Blood pressure and hypertension in diabetes. Am J Epidemiol 1985;122:75-89.
2. Pell S, D'Alonzo CA: Some aspects of hypertension in diabetes mellitus. JAMA 1967;202:104-110.
3. Nelson RG, Kunzelman CL, Pettitt DJ, et al: Albuminuria in Type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabe- tologia 1989;32:870-876.
4. Gall M-A, Skott P, Damsbo P, et al: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in non-insulin-dependent diabetes mellitus. Diabetologia 1991;34:655-661.
5. The Working Group on Hypertension in Diabetes: Statement on hypertension in diabetes mellitus. Final report. Arch Intern Med 1987;147:830-842.
6. Knowler WC, Bennett PH, Ballantine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure. A six year follow-up study in Pima Indians. N Engl J Med 1980;302:645-650.
7. Parving H-H, Viberti GC, Keen H, et al: Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-949.
8. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. Br Med J 1989;299:230-233.
9. Mathiesen ER, Borch-Johnsen K, Jensen DV, et al: Improved survival in patients with diabetic nephropathy. Diabetologia 1989;32:884-886.
10. Struthers AD: The choice of antihypertensive therapy in the diabetic patient. Postgrad Med J 1985;61:563-569.
11. Dornhorst A, Powell SH, Pensky J: Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in Type II diabetics without alteration of insulin secretion. Lancet 1985; 1:123-126.
12. Fuh MM-T, Sheu WH-H, Shen DC, et al: Metabolic effects of diuretic and -blocker treatment of hypertension in patients with non-insulin-dependent diabetes mellitus. Am J Hypertens 1990;3:387-390.
13. Rett K, Wicklmayr M, Dietze GJ, et al: Effects of captopril (C) and metoprolol (M) on glycémie control, lipid profile and coronary risk in hypertensive patients with noninsulin-dependent diabetes (NIDDM) (abst). Diabetes 1990;39(suppl 1):172.
14. Wright AD, Barber SG, Kendall MJ, et al: Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. Br Med J 1979;1:159-161.
15. Bilo HJG, Westerman RF, Nicolas-Mercus AM, et al: Effects of enalapril with and without hydrochlorothiazide in hypertensive patients with non-insulin-dependent diabetes mellitus. Diabetes Research 1988;9:21-25.
16. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-873.
17. Guidelines for the treatment of mild hypertension: Memorandum from the WHÔ/ISH. Hypertension 1986; 8:957-961.
18. Wiinberg N, Nygart J, Sengelov H, et al: Oscillometric measurement of the blood pressure. Ugeskr Laeger 1988;150:1282-1284.
19. Association for the Advancement of Medical Instrumentation: American National Standard for Electronic or Automated Sphygmomanometers. Washington DC, AAMI, 1987.
20. Goldstein DE, Peth SB, England JD, et al: Effects of acute changes in blood glucose on HbAlc. Diabetes 1980; 29:623-628.
21. Kostner GM, Molinary E, Pichler P: Evaluation for a new HDL2/HDL3-quantitation method based on precipitation with polyethylene glycol. Clin Chem Acta 1985; 148:139-147.
22. Itaya K, Michio U: Colorimetric determination of free fatty acids in biological fluids. J Lipid Res 1965;6:16-20.
23. Ullmann R, Bonitz K: Vollmechanisierte kinetische Messung von Kreatinin. Medizinische Laboradorium 1976; 29:137-145.
24. Andersen I, Hannibal S: Analytical and economical optimization of a glucose method with immobilized enzymes. Journal of Automatic Chemistry 1983;4:188-192.
25. Heding LG: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8:260-266.
26. Heding LG; Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;11:541-548.
27. Brôchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271-274.
28. Christensen C, Orskov C: Rapid screening PEG radioimmunoassay for quantication of pathological microalbuminuria. Diabetic Nephropathy 1984;3:92-94.
29. Apelqvist J, Castenfors J, Larsson J, et al: Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 1989; 6:373-378.
30. Hilsted J, Jensen SB: A simple test for autonomic neuropathy in juvenile diabetes. Acta Med Scand 1979; 205:385-387.
31. Hilsted J: Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. Diabetes 1982;31:730-737.
32. Dunnett CW: New tables for multiple comparisons with a control. Biometrics 1964;20:482-491.
33. Drury PH: Diabetes and arterial hypertension. Diabeto- logia 1983;24:1-9.
34. Anderson JV, Struthers AD, Ball JA, et ah Metabolic effects of five different antihypertensive agents in noninsulin-dependent diabetes mellitus (abst). Diabetologia 1990;33(suppl):A145.
35. Medical Research Council Working Party on Mild to Moderate Hypertension: Adverse reactions to bendro- fluazide and propranolol for the treatment of mild hypertension. Lancet 1981;2:539-542.
36. Pollare T, Lithell H, Selinus I, et al: Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 1989;298:1152-1157.
37. Corcoran JS, Perkins JE, Hoffbrand BI, et al: Treating hypertension in non - insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide. Diabetic Med 1987;4:164-168.
38. Helgeland A, Strommen R, Hagelund CH, et al: Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. Lancet 1986;1:872-875.
39. Carlsen JE, Kober L, Torp-Pedersen C, et al: Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. Br Med J 1990;300:975-978.
40. Betteridge DJ: Lipids, diabetes, and vascular disease: the time to act. Diabetic Med 1989;6:195-218.
41. Seviour PW, Teal TK, Richmond W: Serum lipids, lipoproteins and macro vascular disease in non-insulindependent diabetics: a possible new approach to prevention. Diabetic Med 1988;5:166-171.
42. Reaven GM: Abnormal lipoprotein metabolism in noninsulin-dependent diabetes mellitus. Pathogenesis and treatment. Am J Med 1987;83(suppl 3A):31-39.
43. Brand FN, Abbott RD, Kännel WB: Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38:504-509.
44. Roberts DH, Tsao Y, McLoughlin GA, et al: Placebocontrolled comparison of captopril, atenolol, labetolol, and pindolol in hypertension complicated by intermittent claudication. Lancet 1987;2:650-653.
45. Edwards CRW, Padfield PL: Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet 1985;1:30-34.
46. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.